-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Vor Biopharma, Raises Price Target to $1

Benzinga·06/27/2025 14:04:55
Listen to the news
Baird analyst Jack Allen maintains Vor Biopharma (NASDAQ:VOR) with a Neutral and raises the price target from $0.25 to $1.